Compare EEIQ & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EEIQ | SILO |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Apparel |
| Sector | Real Estate | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 8.0M |
| IPO Year | 2021 | N/A |
| Metric | EEIQ | SILO |
|---|---|---|
| Price | $0.31 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 62.1K | ★ 132.6K |
| Earning Date | 01-30-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,358,301.00 | $72,102.00 |
| Revenue This Year | N/A | $1.86 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 44.99 | N/A |
| 52 Week Low | $0.23 | $0.36 |
| 52 Week High | $1.74 | $3.37 |
| Indicator | EEIQ | SILO |
|---|---|---|
| Relative Strength Index (RSI) | 37.40 | 42.14 |
| Support Level | $0.33 | $0.42 |
| Resistance Level | $0.35 | $0.46 |
| Average True Range (ATR) | 0.02 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 39.04 | 50.52 |
EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.